mkaiz...This is news...it is hardly great news, and I'm saying it's actually bad news. They aren't saying anything here that they haven't said in the past...looking to develop the pipeline, positive about the litigation...etc. They have said these things 2 years ago...actually 2 years ago they were done with preclinicals for CONJUMAB and now they are going to start more? That means they are no where near what Chain was projecting 2 years ago. Don't even get me started on Chain...they are keeping this guy as a consultant? That's like having the other teams Coach that you're playing telling you how to beat them. If the BOD have just come up with this plan just over the last several months then what did we hire EVLI for a year ago? What happened to RV03? Intellect said it could be a potential vaccine for ALZ and now they don't even mention it...what happened to it? Did it get absorbed into TauC-3 platform? It is good they reduced the debt, but what is the cost to common shareholders? Maza is the new CEO...Maza and the BOD were looking for a CEO and they took a year to tell us that it was going to be Maza...again, he was the CEO in the past and was the reason for the toxic financing in the first place. Tell me what is exactly so great about this news mkaiz, don't just regurgitate what somebody else has already written.
